FDA Expands Conference Cooperative Agreement Program to Enhance Stakeholder Input on Medical Product Surveillance

Summary

The Food and Drug Administration (FDA) is expanding its Conference Cooperative Agreement Program, awarded to the Engelberg Center for Health Care Reform at the Brookings Institution, to gather broad stakeholder input on FDA initiatives related to medical product surveillance and information dissemination.